Insight Molecular Diagnostics Inc. (IMDX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5M 3M 4.5M Q3 '24: 709K Q4 '24: 1.9M Q1 '25: 3.8M Q2 '25: 4.3M Q3 '25: 4.4M Q4 '25: 4.1M Q1 '26: 1.9M Q2 '26: 1.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 900K 1.8M 2.7M Q3 '23: 503K Q4 '24: 740K Q1 '25: 2M Q2 '25: 2.3M Q3 '25: 2.4M Q4 '25: 2.3M Q1 '26: 988K Q2 '26: 807K Q3 '23 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-75M -50M -25M 0 25M 50M 75M Q3 '24: -43.6M Q4 '24: -61M Q1 '25: -58.6M Q2 '25: -63.8M Q3 '25: -61.3M Q4 '25: -51.1M Q1 '26: -48.7M Q2 '26: -50.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-75M -50M -25M 0 25M 50M 75M Q3 '24: -43.1M Q4 '24: -60.7M Q1 '25: -58.2M Q2 '25: -63.4M Q3 '25: -60.8M Q4 '25: -50.2M Q1 '26: -47.8M Q2 '26: -49.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 700K 1.4M 2.1M Q3 '24: 593K Q4 '24: 1.1M Q1 '25: 1.8M Q2 '25: 1.9M Q3 '25: 2M Q4 '25: 1.8M Q1 '26: 961K Q2 '26: 863K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-30M -20M -10M 0 10M 20M 30M Q3 '24: -19.8M Q4 '24: -20.7M Q1 '25: -22.7M Q2 '25: -22.9M Q3 '25: -22M Q4 '25: -22.2M Q1 '26: -24M Q2 '26: -27.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q3 '24: -20.3M Q4 '24: -21.2M Q1 '25: -23.5M Q2 '25: -23.9M Q3 '25: -23.9M Q4 '25: -25.4M Q1 '26: -27.5M Q2 '26: -31M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '24: 8.3M Q2 '24: 12.9M Q3 '24: 13.7M Q1 '25: 25.7M Q2 '25: 32M Q3 '25: 32M Q1 '26: 34.5M Q2 '26: 36.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '24: -4.54 Q4 '24: -4.77 Q1 '25: -3.90 Q2 '25: -3.84 Q3 '25: -3.20 Q4 '25: -1.64 Q1 '26: -1.50 Q2 '26: -1.51 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.